Clinical Trial Update: Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A multicenter Phase 3 follow-up report comparing exemestane with megestrol acetate in postmenopausal women with metastatic breast cancer; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)
• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Pfizer | Conditions: Metastatic Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2011-03-14